Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-07-17

FDA Approved: DANTROLENE SODIUM — Supplemental Application (Endo USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Dantrolene Sodium submitted by Endo USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dantrolene Sodium (Dantrolene Sodium)

Snippet

SUPPL AP for DANTROLENE SODIUM (DANTROLENE SODIUM)